WEKO3
アイテム
Clinical Evaluation of Immune Response in Patients with Lung Cancer
http://hdl.handle.net/10069/15621
http://hdl.handle.net/10069/15621495d1c36-c44c-4279-b9b0-ff70ce13b437
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
acta25_01_02_t.pdf (694.0 kB)
|
|
| Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2008-03-10 | |||||
| タイトル | ||||||
| タイトル | Clinical Evaluation of Immune Response in Patients with Lung Cancer | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | departmental bulletin paper | |||||
| 著者 |
Tomita, Masao
× Tomita, Masao× Koga, Yasunori× Shibata, Koichiro× Matsumoto, Kazuhisa× Onitsuka, Toshio× Sakoda, Koichiro× Maeda, Takami× Hamasuna, Shigehito× Kariya, Toshiro× Matsuzaki, Yasunori× Yonezawa, Tsutomu× Yoshioka, Makoto |
|||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92083 | |||||
| 姓名 | 富田, 正雄 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92084 | |||||
| 姓名 | 古賀, 保範 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92085 | |||||
| 姓名 | 柴田, 紘一郎 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92086 | |||||
| 姓名 | 松本, 和久 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92087 | |||||
| 姓名 | 鬼塚, 敏男 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92088 | |||||
| 姓名 | 迫田, 耕一郎 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92089 | |||||
| 姓名 | 前田, 隆美 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92090 | |||||
| 姓名 | 浜砂, 重仁 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92091 | |||||
| 姓名 | 仮屋, 敏郎 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92092 | |||||
| 姓名 | 松崎, 泰憲 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92093 | |||||
| 姓名 | 米沢, 勤 | |||||
| 著者別名 | ||||||
| 識別子Scheme | WEKO | |||||
| 識別子 | 92094 | |||||
| 姓名 | 吉岡, 誠 | |||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | In patients with lung cancer, the immune response was observed with an analysis of various factors which mostly related to its prognosis. Its response was extremly depressed in the course of following surgery in advanced cases of stage III and IVas well as in unresectable cases for lung cancer, compared with those of stage I and II . Furthermore, it showed that the high levels of immune response were seen in those of long term survivors given OK-432 during follow-up period. It was obvious from this study that the use of OK-432 was suitable for activation of the immune reaction against host as one of the immunopotentiators. Meanwhile, from the immunological mechanism of view, the hyperactivity of immune response enable the patient to be free from recurrence of cancer for a long term following surgery, in contrast the low level of the immune response showed to be poor prognosis owing to early appearance of recurrence. Furthermore, the effectiveness in use of OK-432 was clinically presented in patients with malignant pleural effusion, which showed direct cytocidal action of OK-432 given intrapleurally with a 10 or 14 days interval. | |||||
| 書誌情報 |
Acta medica Nagasakiensia 巻 25, 号 1-4, p. 8-15, 発行日 1980-10-25 |
|||||
| ISSN | ||||||
| 収録物識別子タイプ | ISSN | |||||
| 収録物識別子 | 00016055 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AA00508430 | |||||
| 著者版フラグ | ||||||
| 出版タイプ | VoR | |||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
| sortkey | ||||||
| 値 | P00008-P00015 | |||||
| 引用 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Acta medica Nagasakiensia. 1980, 25(1-4), p.8-15 | |||||
